EP0031335A1 - Substrat de lipase - Google Patents

Substrat de lipase

Info

Publication number
EP0031335A1
EP0031335A1 EP80901159A EP80901159A EP0031335A1 EP 0031335 A1 EP0031335 A1 EP 0031335A1 EP 80901159 A EP80901159 A EP 80901159A EP 80901159 A EP80901159 A EP 80901159A EP 0031335 A1 EP0031335 A1 EP 0031335A1
Authority
EP
European Patent Office
Prior art keywords
substrate
concentration
emulsion
surface active
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP80901159A
Other languages
German (de)
English (en)
Other versions
EP0031335A4 (fr
Inventor
John Charles Mazza
Louis John Dunka, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Hospital Supply Corp
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of EP0031335A1 publication Critical patent/EP0031335A1/fr
Publication of EP0031335A4 publication Critical patent/EP0031335A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase

Definitions

  • Lipase is an enzyme secreted by the pancreas and is utilized in the digestion of triglycerides. Determination of lipase concentration in blood and other biological fluids is useful for the diagnosis of pancreatic dysfunction.
  • the enzyme is an esterase which acts only on insoluble triglycerides, and the rate of lipase hydrolysis is dependent upon the surface area of the triglyceride available for contact with the enzyme.
  • the triglyceride advantageously occurs as an aqueous emulsion. Lipase determinations are conventionally turbidimetric, titrametric, or colormetric.
  • aqueous emulsion of a lipase-hydrolyzable triglyceride to which the lipase- containing sample is added.
  • rate of decrease in turbidity is proportional to the lipase concentration in the sample.
  • the substrate emulsion used in turbidimetric assays is usually buffered to maintain a pH conducive to optimum enzyme action.
  • titrametric assays a basic solution is titrated into the substrate emulsion to neutralize free fatty acids as they are liberated by the enzyme. The rate of addition of base is thus proportional to the enzyme concentration.
  • Colormetric assays generally involve color forming reactions with the enzyme-liberated glycerol or fatty acids.
  • turbidimetric techniques have involved preparation of a substrate emulsion by the analyst.
  • Such emulsions are conventionally prepared by adding a predetermined amount of a suitable triglyderide, a surface active agent, and a buffer to water and agitating the mixture until a homogeneous emulsion is formed.
  • the turbidity of the emulsion is dependent, to a large extent, upon the manner in which the emulsion is prepared. The procedure is time-consuming, and reproducible emulsions are difficult to obtain. Accordingly, there is a need for a ready-made, reproducible substrate emulsion with which an analyst can conduct rapid and accurate assays.
  • German Offenlegungsschri t 1 961 983 discloses a substrate for titrametric lipase determinations.
  • the substrate is a lyophilized emulsion containing olive oil, a surface active agent, and a protective colloid.
  • the analyst reconstitutes the dry product with water, adds a sample aliquot thereto, and titrates the liberated fatty acids.
  • the emulsion contains a relatively large concentration of triglyceride, e.g. the ratio of olive oil to protective colloid is about 3:1.
  • Turbidimetric assays require relatively dilute emulsions of triglycerides to provide useful optical densities. Because turbidity is quite dependent upon the nature of the emulsion, reproducibility of the emulsion is more critical for turbidi ⁇ metric substrates than for titrametric substrates. Ready-made, stable, turbidimetric substrates have not heretofore been prepared.
  • a substrate for use in a turbidimetric assay for lipase which comprises a lyophilized emulsion of from about 0.5% to about 5 wt.% of a lipase- hydrolyzable triglyceride; a pH-controlling amount of a pH-7 to pH-10 buffer; from about 10 wt.% to about 40 wt.% of a surface active agent; and from about 20 wt.% to about 60 wt.% of a bulking agent.
  • the novel lyophilized lipase substrates of this invention are prepared from aqueous emulsions of a lipase-hydrolyzable triglyceride.
  • triglycerides are generally fatty acid triesters of glycerol, in which the fatty acid substituents contain from about 3 to about 2- ⁇ - carbon atoms, preferably from about 16 to about 20 carbon atoms.
  • Such fatty acids may be aiphatic or olefinic.
  • the triglycerides employed in such substrates may be purified materials such as triolein, tripalmitin, tristearin, trilinolein, stearo-diolein, palmito-oleosterin, and the like, or may be natural materials such as olive oil, peanut oil, sunflower seed oil, coconut oil, and the like.
  • Olive oil is a preferred triglyceride for substrates of this invention, because of its suitability, availability, and comparatively low cost.
  • a triglyceride-emulsifying surface active agent is employed. Any suitable surface active agent may be employed which does not deieteriously affect the other components of the substrate or interfere with the enzymatic reaction.
  • Triglycerides are emulsified in vivo by the action of bile salts, such as physiological salts of desoxycholic acid, tauracholic acid, tauradesoxycholic acid, chenodesoxycholic acid, and the like, and these bile salts are particularly advantageous for the preparation of the substrates of this invention.
  • active agents such as octylphenoxypolyethoxyethanol may be employed; however, certain synthetic detergents act as substrates for lipase, and such compounds should be avoided.
  • the lipase enzyme is most effective at a basic pH, e.g. a pH from about 7 to about 10.
  • a basic pH e.g. a pH from about 7 to about 10.
  • a turbidimetric assay generally utilizes a buffer to control the pH within an enzyme-hydroiyzing range. Accordingly, the substrate of this invention advantageously includes a ⁇ H-7 to pH-10 buffer. Any effective
  • a particularly preferred buffer is tris-(hydroxymethyl)-aminomethane.
  • Other buffers which can be employed include zwitterion buffers such as N-tris(hydroxymethyl) methyl- glycine, glycinamide hydrochloride, N,N-bis(hydroxyethyl)glycine, and
  • the above-identified components are vigorously blended in water to prepare a homogeneous stable emulsion.
  • concentrations of the various ingredients are controlled within general ranges and proportions to each other to provide such an emulsion.
  • concentrations of the various ingredients are controlled within general ranges and proportions to each other to provide such an emulsion.
  • concentrations of the various ingredients are controlled within general ranges and proportions to each other to provide such an emulsion.
  • ingredients in the aqueous emulsion are not critical, because the water will be removed during the lyophilization step, but the relative proportions of the components are important. Nevertheless, sufficient water is used to obtain desirable emulsion properties. Generally, sufficient water is employed to obtain a uniform emulsion. Any water that is used will be
  • the solids content of the aqueous emulsion will range from about the desired concentration of reconstituted lyophilized substrate to about fiv times that concentration. Preferred concentrations are from* about 1 t about 3 times the reconstituted concentration of the substrate.
  • lipase-hydrolyzabie triglyceride i added to water in an amount sufficient to produce an emulsion which, whe
  • ⁇ diluted to the concentration to which the final lyophilized substrate will b reconstituted has an absorbance of from about 0.3 to about 3.
  • absorbance measurements were made at 05nm in a 1 cm cell versu a water blank on a Gilford Model 240 spectrophotometer (Gilford Instru ments, Oberlin, Ohio). Absolute absorbance values may vary from instru ment to instrument, but absorbance is useful for defining the genera optical properties of the emulsion and is an accurate measurement of th reproducibility of emulsions).
  • the optical absorbance of the emulsion is not solely dependent upon triglyceride concentration, but is also affecte by such other factors as the degree of dispersion of the emulsion, and the particular ingredients used.
  • Triglyceride concentrations of from about 100 micromolar to about 425 micromolar are generally employed to obtain an absorbance within the desired range.
  • Preferred concentrations of triglycerides are in the range of from about 200-300 micromolar.
  • the surface active agent is employed in a triglyceride-emulsifying amount, and this amount can vary considerably depending upon the surface active agent used. Generally, for sodium desoxycholate concentrations of surface active agent of from about 0.001 molar to 0.010 molar are employed, with preferred concentrations ranging from 0.004 molar to 0.008 molar.
  • the buffer is employed in a pH-controlling amount, and this amount can vary considerably depending upon the particular buffer used.
  • a concentration of from about 0.015 molar to about 0.1 molar, preferably from about 0.020-0.075 molar is employed.
  • emulsification may be accomplished by any effective means, such as high speed blending, hand homogenation, pressure homogenation, and ultrasonication. Frequently, two or more of these techniques are combined to produce a uniform emulsion.
  • Preferred emulsification tech ⁇ niques are ultrasonication, in which the emulsion is subjected to high energy ultrasonic sound, and pressure homogenation, in which the emulsion is forced at high pressure through small orifices against a baffle plate.
  • Emulsions may be prepared to a standard turbidity by blending appropriate emulsions of various absorbances.
  • a bulking agent is added to the emulsion to provide a matrix for lyophilization for the emulsion.
  • the bulking agent may be any inert, water soluble compound. By inert is meant a compound which does not interfere with the enzyme reaction.
  • Bulking agents which may be employed include hexitols such as mannitol and sorbitol, saccharides, such as sucrose, dextrose, etc., polysaccharides, such a gum acacia, guar gum, xanthan gum, synthetic polymers, such as polyvinylpyrolidone, and the like.
  • the pre ⁇ ferred bulking agent is mannitol.
  • the bulking agent is employed in an amount sufficient to provide a dry uniform, powdery substrate after lyophilization. Generally, the bulking agent is added to the aqueous emulsion at a concentration of from about lmg/ml to about lOmg/ml preferably from about 3mg/ml to about 7mg/ml.
  • the emulsion When the emulsion has been prepared, it is frozen and lyophilized in a conventional manner. Small aliquiots of the emulsion may be added to vials and lyophilized in situ, thus providing a product having a known amount of substrate and which may be reconstituted to an accurate concentration upon addition of a precise volume of water. Alternatively, the emulsion may be lyophilized in bulk and subsequently filled into vials or other suitable containers. It has been found that a powder filling aid, such as polyethylene glycol may facilitate such filling operations. Utilizing the procedure described above, the lyophilzed substrate may contain from about 0.5 wt. % to about 5 wt. %, perferably from about 1.0 wt.
  • the lyophilized substrates of this invention have been found to be stable and very reproducible. Initial turbidities of reconstituted products have been found to be controllable within ⁇ 10%. The product is very convenient in that the analyst simply -mixes a predetermined amount of water with the lyophilized substrate. The substrate quickly disperses to form an emulsion which requires no further treatment prior to the addition of sample.
  • Tris-(hydroxymethyl.-aminomethane (60.56g) was dissolved in 950 ml. of deionized water. The temperature of the solution was adjusted to 25 C and the pH adjusted to 9.0. with acid, at which time sodium desozycholate (24.88g) was added. The solution was diluted to 1000 ml.
  • Example II The procedure of Example I is repeated in all essential details except triolein is substituted for olive oil and the emulsification is accomplished by a high speed blending. A stable lyophilized substrate is obtained.
  • Example III The procedure of Example I is repeated in all essential details except sodium tauracholate is substituted of sodium desoxycholate and sucrose is substituted for mannitol. A stable lyophilized substrate is obtained.
  • Example IV The procedure of Example I was repeated in all essential details except the emulsion was lyophilized in bulk and 0.816 grams of poly ⁇ ethylene glycol -4000 is added per gram of the dried product prior to filling into vials.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un nouveau substrat utilise dans les analyses turbidimetiques de lipase contient une emulsion lyophilisee d'un triglyceride hydrolysable avec une lipase, un tampon, un agent tensio-actif, et un agent de gonflement.
EP19800901159 1979-06-04 1980-12-15 Substrat de lipase. Withdrawn EP0031335A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4546779A 1979-06-04 1979-06-04
US45467 1979-06-04
EP80301476A EP0021572A1 (fr) 1979-06-04 1980-05-06 Substrat pour la détermination turbidimétrique de lipase et procédé de préparation de ce substrat
EP80301476 1980-05-06

Publications (2)

Publication Number Publication Date
EP0031335A1 true EP0031335A1 (fr) 1981-07-08
EP0031335A4 EP0031335A4 (fr) 1981-10-27

Family

ID=21938055

Family Applications (2)

Application Number Title Priority Date Filing Date
EP80301476A Withdrawn EP0021572A1 (fr) 1979-06-04 1980-05-06 Substrat pour la détermination turbidimétrique de lipase et procédé de préparation de ce substrat
EP19800901159 Withdrawn EP0031335A4 (fr) 1979-06-04 1980-12-15 Substrat de lipase.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP80301476A Withdrawn EP0021572A1 (fr) 1979-06-04 1980-05-06 Substrat pour la détermination turbidimétrique de lipase et procédé de préparation de ce substrat

Country Status (5)

Country Link
EP (2) EP0021572A1 (fr)
JP (1) JPS56500598A (fr)
DK (1) DK44981A (fr)
ES (1) ES8105393A1 (fr)
WO (1) WO1980002697A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503146A (en) * 1980-10-01 1985-03-05 Technicon Instruments Corporation Method for eliminating turbidity in a biological fluid and reagent therefor
DE3365307D1 (en) * 1983-09-07 1986-09-18 American Hospital Supply Corp Reconstitutable dry reagent for diagnostic purposes and method of manufacture
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
ES2034037T3 (es) * 1987-07-01 1993-04-01 Abbott Laboratories Un metodo turbidimetrico mejorado para la determinacion de lipasa en suero.
FR2619219A1 (fr) * 1987-08-07 1989-02-10 Strasbourg I Louis Pasteur Uni Reactif sec pour la determination de la lipase pancreatique, procede de preparation dudit reactif sec et reactif sec et reactif sous forme d'emulsion obtenu par reconstitution du reactif sec.
JP2711332B2 (ja) * 1988-04-15 1998-02-10 株式会社ヤトロン 非水溶性物質の透明な水溶液が得られる凍結乾燥品の製造方法
FR2696193B1 (fr) * 1992-09-25 1994-12-09 Interfacial Technology Concept Procédé de mesure de l'activité des phospholipases.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073537A5 (fr) * 1969-12-10 1971-10-01 Boehringer Mannheim Gmbh Reactif pour la determination de l'activite de la lipase et procede pour le fabriquer
US3917515A (en) * 1974-03-13 1975-11-04 Jack M Goldberg Serum lipase method and medium
FR2350604A1 (fr) * 1976-05-04 1977-12-02 Du Pont Procede pour determiner l'activite de la lipase en utilisant un nouveau reactif triglyceride et procede pour preparer ce reactif
EP0014252A1 (fr) * 1979-02-05 1980-08-20 Roche Diagnostics GmbH Réactif pour la détermination de la lipase et procédé pour sa préparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH506792A (de) * 1968-09-20 1971-04-30 Merck Ag E Neues Mittel und Verfahren zur Lipasebestimmung
US3986930A (en) * 1974-05-28 1976-10-19 Dainippon Pharmaceutical Co., Ltd. Lipase activity determining method and reagent
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
US4140579A (en) * 1977-04-04 1979-02-20 Moncla Bernard J Method of testing for phospholipases using a composition containing a uniform dispersion of a phospholipid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073537A5 (fr) * 1969-12-10 1971-10-01 Boehringer Mannheim Gmbh Reactif pour la determination de l'activite de la lipase et procede pour le fabriquer
US3917515A (en) * 1974-03-13 1975-11-04 Jack M Goldberg Serum lipase method and medium
FR2350604A1 (fr) * 1976-05-04 1977-12-02 Du Pont Procede pour determiner l'activite de la lipase en utilisant un nouveau reactif triglyceride et procede pour preparer ce reactif
EP0014252A1 (fr) * 1979-02-05 1980-08-20 Roche Diagnostics GmbH Réactif pour la détermination de la lipase et procédé pour sa préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8002697A1 *

Also Published As

Publication number Publication date
ES492181A0 (es) 1981-06-01
WO1980002697A1 (fr) 1980-12-11
JPS56500598A (fr) 1981-05-07
DK44981A (da) 1981-02-02
ES8105393A1 (es) 1981-06-01
EP0021572A1 (fr) 1981-01-07
EP0031335A4 (fr) 1981-10-27

Similar Documents

Publication Publication Date Title
US4343897A (en) Reagent for the determination of lipase and process for preparing same
US3413198A (en) Reagents and method for assaying biological samples
Denz On the histochemistry of the myoneural junction
Main Kinetic evidence of multiple reversible cholinesterases based on inhibition by organophosphates
US3527674A (en) Reagent material and method for urea assay
EP0031335A1 (fr) Substrat de lipase
NO151012B (no) Substratpreparat og anvendelse derav
DE3886204T2 (de) Lyophilisat einer wässrigen Lösung von Triglyzeridsubstrat zur Bestimmung von Lipase.
Schmidli et al. Lipase-catalyzed reactions in reverse micelles formed by soybean lecithin
JP2700501B2 (ja) リパーゼ定量用単一試薬系およびその製造方法
Walde A colorimetric determination of fatty acids as a new assay of lipases in reverse micelles
US5378609A (en) Lipase single reagent system
IE44834B1 (en) Method of determining lipase activity using a novel triglyceride reagent and method for preparing that reagent
Inamdar et al. Effect of age on oxidative phosphorylation in tissues of hamsters
JPH0154997B2 (fr)
US3527331A (en) Reagent for assaying aldolase
US3528888A (en) Reagent and method for assaying alpha-hydroxybutyrate dehydrogenase
SU656527A3 (ru) Способ получени ферментного субстрата на твердом носителе
US4151043A (en) Enzyme determination method
US3527332A (en) Method for assaying glutamate pyruvate transaminase
Suzuki et al. A simple fluorometric assay for type B monoamine oxidase activity in rat tissues
Kuczenski et al. Fructose 1, 6-diphosphate enhanced inactivation of yeast pyruvate kinase at 23°. Evidence for a stabilized dimer intermediate
US3573171A (en) Laboratory reagent for assay of lactic acid
EP0147430A1 (fr) Procede et composition pour la determination de la gamma glutamyle transpeptidase
GB2065881A (en) Lipase determination method and reagent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): CH DE FR GB NL SE

17P Request for examination filed

Effective date: 19810605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19830328

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MAZZA, JOHN CHARLES

Inventor name: DUNKA, LOUIS JOHN, JR.